O medicamento e o sistema de saúde
Francisco Batel Marques
Cardernos Saúde e Sociedade nº 1021, 41-43, 97-101
2011
Safety evaluation of pharmacological interventions: a review of recent published meta-analysis
Alves C, Macedo AF, Craveiro N, Batel Marques F
Pharmacoepidemiol Drug Saf 2011;20:S351
2011
Increased severity of adverse drug reactions reported from hospitals.
Batel Marques FJ, Alves C, Craveiro N, Fontes-Ribeiro C, Macedo AF
Pharmacoepidemiol Drug Safe 2011;20:S330
2011
Omissão de fármacos modificadores do risco cardiovascular em idosos admitidos numa Unidade de Acidentes Vasculares Cerebrais.
Borges EP, Macedo AF
Rev Port Clin Geral 2011;27:140-150
2011
Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.
Alves C, Macedo AF, Batel Marques F
Pharmacotherapy 2011;31(10):357e
2011
Fecundação in vitro em Portugal: um estudo de custo-efectividade.
Silva V, Pita Barros P, Lourenço O, Batel-Marques F.
Rev Port Farmacoter 2011;3:139-153
2011
Política do Medicamento.
Batel Marques F
Rev Port Farmacoter 2011;3:165-168
2011
Prescrição de Medicamentos Off-Label.
Batel Marques F, Cunha Vaz J
Rev Port Farmacoter 2011;3:169-171
2011
Data sources on drug safety evaluation: a review of recent published meta-analysis.
Alves C, Batel Marques F, Macedo AF
Pharmacoepidemiol Drug Saf 2012;21(1):21-33
2011
Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.
Alves C, Batel-Marques F, Macedo AF.
J Cardiovasc Pharmacol Therap 2011 1 Dec. doi: 10.1177/1074248411427402
2011
